We use cookies to make your experience better. To comply with the new e-Privacy directive, we need to ask for your consent to set the cookies. Learn more.
Share this :
Print
Miltenyi Biotec Clinimacs® Formulation & Cryo Kit
Miltenyi Biotec Clinimacs Formulation Solution Has Been Developed For Ex Vivo Cell Based Drug Product Formulation.Clinimacs Cryo Supplement, 3x Has Been Developed For Ex Vivo Cell - MLTY (Additional S&H or Hazmat Fees May Apply)
List Price
$8,959.50
Your Price
$8,959.50
HOW MUCH YOU SAVE:
0.00 %
NETA PART: | MLTY-170-076-358 |
MFG.PART: | 170-076-358 |
UNSPSC: | 41116113 |
Manufacturer: | Miltenyi Biotec |
Miltenyi Biotec CliniMACS® Formulation Solution is intended as excipient for processing of human cells from heterogeneous cell populations in combination with the CliniMACS Prodigy® System. The Formulation Solution consists of a salt solution which is already supplemented with 2.5% human serum albumin (HSA). | CliniMACS Cryo Supplement, 3× is intended as excipient together with the CliniMACS Formulation Solution for processing of human cells from heterogeneous cell populations in combination with the CliniMACS Prodigy® System. The Cryo Supplement 3× consists of a sugar solution containing 22.5% DMSO. In combination with the CliniMACS Formulation Solution the Cryo Supplement 3× serves as a freezing solution with 7.5% DMSO final concentration. Both products are provided as ready-to-use solutions in bags and can be sterile welded onto tubes of a CliniMACS Prodigy Tubing Set. | | - MLTY (Additional S&H or Hazmat Fees May Apply)
SKU | MLTY-170-076-358 |
---|---|
Supplier Part Number | 170-076-358 |
UM | EA |
UNSPSC | 41116113 |
Manufacturer | Miltenyi Biotec |
MSDS URL | https://www.miltenyibiotec.com/ds/170-076-358 |
ProductLine | MLTY |
Qty | 1 |
MinOrderQty | 1 |
Weight | 7.00 |
Lead Time | 5 Business Days |
Hazardous | N |